Bilateral Risk for Subsequent Breast Cancer After Lobular Carcinoma-In-Situ: Analysis of Surveillance, Epidemiology, and End Results Data
- 20 August 2005
- journal article
- breast cancer
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (24), 5534-5541
- https://doi.org/10.1200/jco.2005.04.038
Abstract
Purpose Noninvasive lesions involving the lobules of the breast are increasingly diagnosed as incidental microscopic findings at the time of lumpectomy or core-needle biopsy. We investigated the incidence rates of invasive breast cancer (IBC) after a diagnosis of lobular carcinoma-in-situ (LCIS) by using Surveillance, Epidemiology, and End Results (SEER) data. Patients and Methods Patients (N = 4,853) having a diagnosis of primary LCIS in the time period of 1973 to 1998 were identified using the SEER Public Use CD-ROM data. The database was then searched for patients with subsequent primary IBC occurrences (n = 350). The clinical and pathologic characteristics of patients with subsequent primary IBCs were compared with the characteristics of patients with primary IBCs attained during the same time period (N = 255,114). Results The incidence of IBC increased over time from diagnosis of LCIS, with 7.1% ± 0.5% incidence of IBC at 10 years. IBCs detected after partial mastectomy occurred in either breast (46% ipsilateral and 54% contralateral); however, after mastectomy, most IBCs were contralateral (94.7%). IBCs occurring after LCIS more often represented invasive lobular histology (23.1%) compared with primary IBCs (6.5%). The standardized incidence ratio (the ratio of observed to expected cases) for developing IBC was 2.4 (95% CI, 2.1 to 2.6) adjusted for age and year of diagnosis. Conclusion LCIS is associated with increased risk of subsequent invasive disease, with equal predisposition in either breast. The minimum risk of developing IBC after LCIS is 7.1% at 10 years.Keywords
This publication has 35 references indexed in Scilit:
- Lobular neoplasia on core‐needle biopsy—Clinical significanceCancer, 2004
- Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort studyThe Lancet, 2003
- Changing Incidence of Lobular Carcinoma in situ of the BreastBreast Cancer Research and Treatment, 2002
- American Joint Committee on Cancer Prognostic Factors Consensus ConferenceCancer, 1999
- Lobular carcinoma in situ of the breastSeminars in Surgical Oncology, 1996
- The Continuing Dilemma of Lobular Carcinoma In SituArchives of Surgery, 1992
- Lobular neoplasia of the breast: Higher risk for subsequent invasive cancer predicted by more extensive diseaseHuman Pathology, 1991
- Lobular Carcinoma In Situ: A Rare Form of Mammary CancerCA: A Cancer Journal for Clinicians, 1982
- Lobular neoplasia (so-called lobular carcinoma in situ) of the breastCancer, 1978
- Lobular carcinomain Situ of the breast:An approach to rational treatmentCancer, 1977